Sensus Healthcare, Inc. (SRTS) Analysts See $-0.03 EPS; 4 Analysts Covering Columbus McKinnon (CMCO)

April 17, 2018 - By Ellis Scott

Columbus McKinnon Corporation (NASDAQ:CMCO) Logo

Among 5 analysts covering Columbus McKinnon (NASDAQ:CMCO), 4 have Buy rating, 1 Sell and 0 Hold. Therefore 80% are positive. Columbus McKinnon had 10 analyst reports since July 29, 2015 according to SRatingsIntel. On Thursday, January 26 the stock rating was upgraded by Sidoti to “Buy”. The rating was maintained by Roth Capital with “Buy” on Thursday, November 2. The firm earned “Buy” rating on Wednesday, July 29 by Sidoti. The company was maintained on Wednesday, January 10 by Seaport Global. The stock has “Neutral” rating by Seaport Global Securities on Monday, January 18. The stock of Columbus McKinnon Corporation (NASDAQ:CMCO) has “Buy” rating given on Monday, January 23 by Seaport Global Securities. Zacks downgraded the stock to “Sell” rating in Monday, September 21 report. Sidoti downgraded Columbus McKinnon Corporation (NASDAQ:CMCO) on Wednesday, December 7 to “Neutral” rating. The company was initiated on Friday, July 28 by Roth Capital. As per Friday, January 15, the company rating was downgraded by Seaport Global Securities. See Columbus McKinnon Corporation (NASDAQ:CMCO) latest ratings:

10/01/2018 Broker: Seaport Global Rating: Buy New Target: $50.0 Maintain
02/11/2017 Broker: Roth Capital Rating: Buy New Target: $41.0 Maintain

Analysts expect Sensus Healthcare, Inc. (NASDAQ:SRTS) to report $-0.03 EPS on May, 3.They anticipate $0.09 EPS change or 75.00% from last quarter’s $-0.12 EPS. After having $-0.03 EPS previously, Sensus Healthcare, Inc.’s analysts see 0.00% EPS growth. The stock increased 0.15% or $0.0086 during the last trading session, reaching $5.8786. About 13,898 shares traded or 154.92% up from the average. Sensus Healthcare, Inc. (NASDAQ:SRTS) has risen 32.96% since April 17, 2017 and is uptrending. It has outperformed by 21.41% the S&P500.

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. The company has market cap of $79.59 million. It offers SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameter. It currently has negative earnings. The firm also provides Sentinel service program, which offers its clients protection for their SRT-100 and SRT-100 Vision systems.

Investors sentiment decreased to 1.41 in Q4 2017. Its down 0.03, from 1.44 in 2017Q3. It worsened, as 11 investors sold Columbus McKinnon Corporation shares while 45 reduced holdings. 30 funds opened positions while 49 raised stakes. 19.49 million shares or 0.27% more from 19.43 million shares in 2017Q3 were reported. Bnp Paribas Arbitrage Sa reported 0% stake. Macquarie Limited accumulated 1.06 million shares. Nordea Investment Mngmt Ab accumulated 0.01% or 93,395 shares. Penn Capital Mngmt Com stated it has 59,999 shares. Ameriprise Financial Incorporated, a Minnesota-based fund reported 63,836 shares. Howe And Rusling invested in 2,850 shares. New York-based Lucus Advsrs Lc has invested 0.41% in Columbus McKinnon Corporation (NASDAQ:CMCO). Tiaa Cref Investment Mngmt Ltd Liability invested 0% of its portfolio in Columbus McKinnon Corporation (NASDAQ:CMCO). 128,936 are owned by Comml Bank Of America De. 43,235 are owned by Victory Management. James Investment Research holds 27,680 shares. Kennedy Capital Management Inc has invested 0.23% of its portfolio in Columbus McKinnon Corporation (NASDAQ:CMCO). Dimensional Fund Advsrs Limited Partnership holds 1.46 million shares or 0.02% of its portfolio. Cambridge Research Advisors, Iowa-based fund reported 18,290 shares. Connor Clark And Lunn Inv Management Ltd holds 0% or 15,125 shares.

The stock increased 1.00% or $0.367 during the last trading session, reaching $36.897. About 13,683 shares traded. Columbus McKinnon Corporation (NASDAQ:CMCO) has risen 47.04% since April 17, 2017 and is uptrending. It has outperformed by 35.49% the S&P500.

Since December 13, 2017, it had 0 insider purchases, and 5 selling transactions for $223,629 activity. The insider Korman Alan S sold 2,000 shares worth $74,780. Stewart John H. sold $13,220 worth of stock.

Columbus McKinnon Corporation (NASDAQ:CMCO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: